Mayo genome consortia: A genotype-phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels

Mayo Clinic Proceedings

Volumn 86, Issue 7, 2011, Pages 606-614

  Bielinski, Suzette J ^a   Chai, High Seng ^a   Pathak, Jyotishman ^a   Talwalkar, Jayant A ^a   Limburg, Paul J ^a   Gullerud, Rachel E ^a   Sicotte, Hugues ^a   Klee, Eric W ^a   Ross, Jason L ^a   Kocher, Jean Pierre A ^a   Kullo, Iftikhar J ^a   Heit, John A ^a   Petersen, Gloria M ^a   De Andrade, Mariza ^a   Chute, Christopher G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CHROMOSOME 12P; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; GENE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SLCO1B1 GENE; UGT1A GENE; VENOUS THROMBOEMBOLISM;

EID: 79959693383     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0178     Document Type: Article

References (20)

1. McCarty CA, Chisholm RL, Chute CG, et al; eMerge Team. The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics. 2011;4(1):13.
2. Kullo IJ, Fan J, Pathak J, Savova GK, Ali Z, Chute CG. Leveraging informatics for genetic studies: use of the electronic medical record to enable a genome-wide association study of peripheral arterial disease. J Am Med Inform Assoc. 2010;17(5):568-574.
3. Bathum L, Petersen HC, Rosholm JU, Hyltoft Petersen P, Vaupel J, Christensen K. Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem. 2001;47(1):81-87. (Pubitemid 32064279)
4. Johnson AD, Kavousi M, Smith AV, et al. Genome-wide association metaanalysis for total serum bilirubin levels. Hum Mol Genet. 2009;18:2700-2710.
5. Sanna S, Busonero F, Maschio A, et al. Common variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemia. Hum Mol Genet. 2009;18:2711-2718.
6. Cornelis MC, Agrawal A, Cole JW, et al. The Gene, Environment Association Studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genet Epidemiol. 2010;34(4):364-372.
7. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41(9):986-990.
8. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010;42(3):224-228.
9. Kang TW, Kim HJ, Ju H, et al. Genome-wide association of serum bilirubin levels in Korean population. Hum Mol Genet. 2010;19(18):3672-3678.
10. Melton PE, Haack K, Göring HH, et al. Genetic influences on serum bilirubin in American Indians: the Strong Heart Family Study. Am J Hum Biol. 2011;23(1):118-125.
11. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40:581-616.
12. Ghosh SS, Lu Y, Lee SW, et al. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1). Biochem J. 2005;392(3):685-692. (Pubitemid 43022749)
13. Hong AL, Huo D, Kim HJ, et al. UDP-glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women. Drug Metab Dispos. 2007;35(8):1254-1261. (Pubitemid 47121764)
14. Lin JP, O'Donnell CJ, Schwaiger JP, et al. Association between the UGT1A1* 28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study. Circulation. 2006;114(14):1476-1481. (Pubitemid 44527002)
15. Lin R, Wang Y, Wang Y, et al. Common variants of four bilirubin metabolism genes and their association with serum bilirubin and coronary artery disease in Chinese Han population. Pharmacogenet Genomics. 2009;19(4):310-318.
16. Lingenhel A, Kollerits B, Schwaiger JP, et al. Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease. Exp Gerontol. 2008;43(12):1102-1107.
17. Borucki K, Weikert C, Fisher E, et al. Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers. Clin Biochem. 2009;42(16-17):1635-1641.
18. Huang CS, Huang MJ, Lin MS, Yang SS, Teng HC, Tang KS. Genetic factors related to unconjugated hyperbilirubinemia amongst adults. Pharmacogenet Genomics. 2005;15(1):43-50.
19. Ieiri I, Suzuki H, Kimura M, et al. Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. Hepatol Res. 2004;30(2):91-95. (Pubitemid 41115270)
20. Zhang W, He YJ, Gan Z, et al. OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation. Clin Exp Pharmacol Physiol. 2007;34(12):1240-1244. (Pubitemid 350013247)